Boosting Immunotherapy with CBD: A Game-Changer for Cancer Care!

Triple Negative Breast Cancer (TNBC) is notoriously tough—few treatment options, aggressive growth. But what if CBD could help turn the tide? Here’s how:

🔬 CBD + Immunotherapy: Recent research on TNBC found that adding CBD to the immune therapy atezolizumab made it more effective! CBD actually upregulated PD-L1, an immune checkpoint inhibitor that TNBC usually doesn’t express enough of—meaning the tumor became more responsive to immunotherapy.

💡 The How: CBD worked through the cGAS–STING pathway—a key immune mechanism that ramps up Type I interferons and PD-L1. With this activation, we saw not only what happened but how CBD made it happen.

✨ Integrative Therapy at its Best: CBD, a natural agent, combined with cutting-edge immunotherapy, took a non-responsive cancer and transformed it into an immune-sensitive target. That’s the power of integrative oncology!

Don’t miss the new Pre-Scribed Podcast episode on YouTube, where we dive deeper into these incredible innovations. 🎙️

Supporting Evidence:
* Kim BG, Kim BR, Kim DY, Kim WY, Kang S, Lee SI, Oh SC. Cannabidiol enhances Atezolizumab efficacy by upregulating PD-L1 expression via the cGAS-STING pathway in triple-negative breast cancer cells. Cancer Immunol Res. 2024 Sep 3. doi: 10.1158/2326-6066.CIR-23-0902.

#CBDforCancer #TripleNegativeBreastCancer #Atezolizumab #CancerBreakthrough #IntegrativeOncology #ImmuneActivation #cGASSTING #PDL1 #CancerFighter #InnovativeTherapies #PreScribedPodcast #HealthRevolution #CancerResearch #DrNathanGoodyear #CancerCare #HealingJourney #CancerAwareness #MakeAmericaHealthyAgain